SCHEMBL4002227

SCHEMBL4002227

CC(C)CN(NC(=O)c1ccc(-c2ccncc2)cc1)C(=O)O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK1 Q13464 11/20 0.51
ROCK2 O75116 10/20 0.51
GSK3B P49841 8/20 0.51
CLK4 Q9HAZ1 8/20 0.51
PRKG1 Q13976 8/20 0.51
RPS6KA5 O75582 7/20 0.51
PKN2 Q16513 7/20 0.51
GSK3A P49840 7/20 0.51
AKT1 P31749 6/20 0.51
PRKCD Q05655 6/20 0.51
PRKG2 Q13237 6/20 0.51
MAPK1 P28482 6/20 0.51
SGK2 Q9HBY8 6/20 0.51
PRKACA P17612 6/20 0.51
PRKX P51817 6/20 0.51
MAP4K4 O95819 5/20 0.51
RPS6KB1 P23443 5/20 0.51
CDC42BPA Q5VT25 5/20 0.51
CDK1 P06493 3/20 0.51
CDK2 P24941 3/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL109823 0.71 KMT2A (0.42) MAPK1CSF1RHDAC1POLB
SCHEMBL108573 0.71 ACACB (0.34) HDAC1HDAC6CSNK1D
SCHEMBL9824905 0.71 POLB (0.51) HDAC1HDAC6SMN1; SMN2NPC1RAB9A
SCHEMBL109511 0.69 HSPA9 (0.44) SMN1; SMN2NPC1RAB9A
SCHEMBL3997806 0.69 KDM4E (0.77) ROCK1ROCK2GSK3BCLK4PRKG1
SCHEMBL2781825 0.69 KMT2A (0.40) CSF1RHDAC1HDAC6
SCHEMBL108808 0.69 RAB9A (0.46) HDAC1HDAC6SMN1; SMN2NPC1RAB9A
SCHEMBL106400 0.69 PSMB8 (0.40) SMN1; SMN2NPC1RAB9A
SCHEMBL4578937 0.68 KMT2A (0.52) ROCK1ROCK2GSK3BCLK4PRKG1
SCHEMBL3093010 0.68 ROCK1 (1.00) ROCK1ROCK2GSK3BCLK4PRKG1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009071576-A1 5-ARYL-1,3,4-OXADIAZOLE-2-AMINES AS NICOTINIC ACETYLCHOLINE RECEPTOR AGONISTS GLAXO GROUP LIMITED (GB) 2009-06-11 WO disclosed